ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 39 filers reported holding ACORDA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $12,883,000 | +11.4% | 13,490,000 | -35.7% | 0.00% | 0.0% |
| Q4 2020 | $11,565,000 | -35.2% | 20,990,000 | 0.0% | 0.00% | -40.0% |
| Q3 2020 | $17,842,000 | -0.6% | 20,990,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $17,946,000 | 0.0% | 20,990,000 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $17,946,000 | +3.7% | 20,990,000 | -9.7% | 0.01% | +20.0% |
| Q4 2019 | $17,314,000 | -19.3% | 23,240,000 | -15.5% | 0.01% | -16.7% |
| Q3 2019 | $21,445,000 | +36.2% | 27,493,000 | +49.0% | 0.01% | +20.0% |
| Q2 2019 | $15,750,000 | +203.5% | 18,447,000 | +210.2% | 0.01% | +150.0% |
| Q1 2019 | $5,189,000 | -14.4% | 5,947,000 | -20.1% | 0.00% | 0.0% |
| Q4 2018 | $6,063,000 | +41.5% | 7,447,000 | +50.5% | 0.00% | +100.0% |
| Q3 2018 | $4,286,000 | +41.6% | 4,947,000 | +59.0% | 0.00% | 0.0% |
| Q2 2018 | $3,027,000 | +6.8% | 3,112,000 | +0.3% | 0.00% | 0.0% |
| Q1 2018 | $2,834,000 | -37.4% | 3,103,000 | -41.7% | 0.00% | 0.0% |
| Q4 2017 | $4,527,000 | +53.9% | 5,320,000 | +64.1% | 0.00% | 0.0% |
| Q3 2017 | $2,941,000 | +692.7% | 3,241,000 | +652.0% | 0.00% | – |
| Q2 2017 | $371,000 | -81.7% | 431,000 | -81.7% | 0.00% | -100.0% |
| Q1 2017 | $2,025,000 | +1346.4% | 2,356,000 | +1201.7% | 0.00% | – |
| Q4 2016 | $140,000 | -4.1% | 181,000 | 0.0% | 0.00% | – |
| Q3 2016 | $146,000 | -6.4% | 181,000 | +1.7% | 0.00% | – |
| Q2 2016 | $156,000 | -1.9% | 178,000 | 0.0% | 0.00% | – |
| Q1 2016 | $159,000 | -22.1% | 178,000 | +1.7% | 0.00% | – |
| Q4 2015 | $204,000 | +26.7% | 175,000 | 0.0% | 0.00% | – |
| Q3 2015 | $161,000 | -12.5% | 175,000 | -1.1% | 0.00% | – |
| Q2 2015 | $184,000 | -39.5% | 177,000 | -39.8% | 0.00% | – |
| Q1 2015 | $304,000 | +79.9% | 294,000 | +100.0% | 0.00% | – |
| Q4 2014 | $169,000 | -33.7% | 147,000 | -39.8% | 0.00% | – |
| Q3 2014 | $255,000 | – | 244,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,586,000 | $3,237,000 | 2.17% |
| Telemetry Investments, L.L.C. | 4,000,000 | $3,610,000 | 1.29% |
| Castle Creek Arbitrage, LLC | 6,000,000 | $5,419,000 | 0.54% |
| Man Investments (CH) AG | 600,000 | $542,000 | 0.46% |
| SSI INVESTMENT MANAGEMENT LLC | 5,683,000 | $5,129,000 | 0.44% |
| CANYON CAPITAL ADVISORS LLC | 29,000,000 | $26,173,000 | 0.39% |
| PFM Health Sciences, LP | 21,362,000 | $19,386,000 | 0.38% |
| IRON Financial LLC | 500,000 | $454,000 | 0.35% |
| Partner Investment Management, L.P. | 373,000 | $338,000 | 0.32% |
| WOLVERINE ASSET MANAGEMENT LLC | 29,555,000 | $26,667,000 | 0.30% |